Literature DB >> 8943954

Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats.

L A Danielson1, K P Conrad.   

Abstract

Rats demonstrate renal vasodilation and hyperfiltration in pregnancy. Because both NO and cGMP biosynthesis are increased in gravid rats and because acute administration of NO synthase inhibitors abrogates renal vasodilation and hyperfiltration, NO most likely mediates the renal circulatory changes of gestation. In the present study, we tested the effect of chronic inhibition of NO synthase on effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) in chronically instrumented, conscious, gravid rats. Because gestation is a relatively long-term condition, we postulated that chronic withdrawal of NO would result in sustained inhibition of renal vasodilation and hyperfiltration. Contrary to our hypothesis, the renal circulatory changes of pregnancy were maintained during chronic blockade of NO synthase. That is, subcutaneous administration of 10 micrograms/min N omega-nitro-L-arginine methyl ester (NAME) for 48 hours did not significantly reduce GFR in either virgin or pregnant rats; thus, hyperfiltration persisted in the latter despite chronic NO synthase blockade. In contrast, ERPF was reduced and effective renal vascular resistance (ERVR) increased in both groups of rats during NAME administration but in a parallel fashion, such that renal vasodilation persisted in the gravid animals despite chronic inhibition of NO synthase. However, with superimposition of acute prostaglandin synthesis inhibition (meclofenamate, 10 mg/kg IV), renal vasodilation and hyperfiltration were abolished; ie, the combined treatments of chronic NO synthase blockade and acute prostaglandin synthesis inhibition led to the equalization of GFR, ERPF, and ERVR in conscious virgin and pregnant rats. Inhibition of prostaglandin synthesis alone had little affect on the renal circulation, as previously reported. In summary, prostaglandins are recruited to maintain renal vasodilation and hyperfiltration during chronic NO synthase blockade in conscious pregnant rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943954     DOI: 10.1161/01.res.79.6.1161

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

2.  Prolonged uterine artery nitric oxide synthase inhibition modestly alters basal uteroplacental vasodilation in the last third of ovine pregnancy.

Authors:  Charles R Rosenfeld; Timothy Roy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

Review 3.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

4.  Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids.

Authors:  László Hortobágyi; Béla Kis; András Hrabák; Béla Horváth; Gergely Huszty; Horst Schweer; Balázs Benyó; Péter Sándor; David W Busija; Zoltán Benyó
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

Review 5.  The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Authors:  Kirk P Conrad; John M Davison
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

Review 6.  Functional vascular changes of the kidney during pregnancy in animals: a systematic review and meta-analysis.

Authors:  Joris van Drongelen; Rob de Vries; Frederik K Lotgering; Paul Smits; Marc E A Spaanderman
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

7.  Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats.

Authors:  Vanessa Meira Ferreira; Clevia Santos Passos; Edgar Maquigussa; Roberto Braz Pontes; Cassia Toledo Bergamaschi; Ruy Ribeiro Campos; Mirian Aparecida Boim
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.